Back to Stocks

SLQT

SelectQuote, Inc.
7 filings tracked
healthcarehealthcare servicesSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

SelectQuote is successfully evolving from a pure-play insurance distributor into a diversified senior healthcare ecosystem.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline earnings growth, SelectQuote's operational core shows signs of fragility. The company's fastest-growing segment, pharmacy, is seeing costs scale rapidly, with cost of goods sold surging 27% year-to-date.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every SLQT filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The latest filing reveals a company in a high-stakes transition, balancing impressive top-line diversification against a volatile balance sheet. While the shift toward healthcare services and pharmacy is driving revenue growth and improving short-term net income, the underlying capital structure remains a primary concern for investors. The reduction in interest expense provides temporary breathing room, but the looming redemption requirements of the senior preferred stock and the variable nature of the new term loan create a high-risk environment. Ultimately, the investment case depends on whether the operational momentum in healthcare services can outpace the financial pressure of its debt and the legal headwinds from ongoing DOJ and securities litigation. The immediate catalyst will be the company's ability to regain NYSE compliance and stabilize its share price, as a delisting would likely trigger a liquidity crisis that could overshadow its operational wins.

Selected Quarter

Core Takeaway

SelectQuote is successfully diversifying its revenue streams, but a precarious capital structure and NYSE compliance issues threaten long-term stability.

Investor Lens

The trade-off is between impressive operational growth in the senior health sector and the high probability of a liquidity event or delisting.

Watch Next

The six-month cure period for NYSE compliance and the impact of the Inflation Reduction Act on carrier reimbursement rates.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.15Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%
bullishMay 5

Net income surged 54% to $40.2 million for the quarter.

earnings beat
80%
bullishMay 5

Operating margins expanded from 5.4% to 8.3%.

margin expansion
70%
neutralMay 5

Refinanced previous debt into a $325M senior secured term loan.

debt restructure
60%
bearishMay 5

Received NYSE notice of non-compliance with minimum share price requirements.

regulatory action
90%

Filing History

10-QMay 5, 2026
Expand Sequence

The latest filing reveals a company in a high-stakes transition, balancing impressive top-line diversification against a volatile balance sheet. While the shift toward healthcare services and pharmacy is driving revenue growth and improving short-term net income, the underlying capital structure remains a primary concern for investors. The reduction in interest expense provides temporary breathing room, but the looming redemption requirements of the senior preferred stock and the variable nature of the new term loan create a high-risk environment. Ultimately, the investment case depends on whether the operational momentum in healthcare services can outpace the financial pressure of its debt and the legal headwinds from ongoing DOJ and securities litigation. The immediate catalyst will be the company's ability to regain NYSE compliance and stabilize its share price, as a delisting would likely trigger a liquidity crisis that could overshadow its operational wins.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.